-
Start Preamble
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings of the Advisory Committee to the Director, National Institutes of Health.
The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend as well as those who need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting sessions will be videocast and can be accessed from the NIH Videocasting website ( http://videocast.nih.gov/).
Name of Committee: Advisory Committee to the Director, National Institutes of Health.
Date: December 8, 2022.
Time: 9:00 a.m. to 5:15 p.m.
Agenda: Performing the Duties of the NIH Director's Report; Updates on ARPA-H and COVID-19; Perspectives on the Current Cooperation with NIH and Priorities for the Future; Proposed Changes to Peer Review Criteria; ACD Working Group Updates; Other Business of the Committee.
Date: December 9, 2022.
Time: 9:00 a.m. to 3:15 p.m.
Agenda: HeLA Genome Data Access Requests; NIH RECOVER Initiative; NIH Efforts in Support of Open Data; Diversity, Equity, Inclusion and Accessibility (DEIA) Strategic Plan; ACD Working Group Updates; Update on UNITE; Other Business of the Committee.
Place: National Institutes of Health, Building 1, Wilson Hall, One Center Drive, Bethesda, MD 20892.
Contact Person: Cyndi Burrus-Shaw, Staff Assistant, National Institutes of Health, Office of the Director, One Center Drive, Building 1, Room 126, Bethesda, MD 20892, 301-496-2433, shawcy@od.nih.gov.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for entrance into on-campus and off-campus facilities. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors attending a meeting on campus or at an off-campus federal facility will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.
Additional Health and Safety Guidance: Before attending a meeting at an NIH facility, it is important that visitors review the NIH COVID-19 Safety Plan at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx for information about requirements and procedures for entering NIH facilities, especially when COVID-19 community levels are medium or high. In addition, the Safer Federal Workforce website has FAQs for visitors at https://www.saferfederalworkforce.gov/faq/visitors/. Please note that if an individual has a COVID-19 diagnosis within 10 days of the meeting, that person must attend virtually. (For more information please read NIH's Requirements for Persons after Exposure at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx and What Happens When Someone Tests Positive at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/test-positive.aspx.) Anyone from the public can attend the open portion of the meeting virtually via the NIH Videocasting website ( http://videocast.nih.gov). Please continue checking these websites, in addition to the committee website listed below, for the most up to date guidance as the meeting date approaches.
Information is also available on the Institute's/Center's home page: http://acd.od.nih.gov, where an agenda and any additional information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS)
Start SignatureDated: November 16, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-25389 Filed 11-21-22; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Published:
- 11/22/2022
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 2022-25389
- Dates:
- December 8, 2022.
- Pages:
- 71342-71342 (1 pages)
- PDF File:
- 2022-25389.pdf